Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sylwia Szafraniec

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Przeglad Lekarski|November 3, 2004
[Anthrax as a bioweapon]Sylwia Szafraniec, Paweł Grzesiowski, Waleria Hryniewicz
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|May 6, 2003
[Modern possibilities of bioterrorism diagnosis]Paweł Grzesiowski, Sylwia Szafraniec, Beata Chmylak, et al.
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|December 17, 2021
Patient care efficiency in primary healthcare - pilot study in Medical and Diagnostical CentreArtur Prusaczyk, Magdalena Bogdan, Paweł Żuk, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|May 24, 2019
Real-World Evidence of Patient Outcome Following Treatment of Advanced Gastrointestinal Stromal Tumor (GIST) with Imatinib, Sunitinib, and Sorafenib in Publicly Funded Health Care in PolandMelania Brzozowska, Waldemar Wierzba, Sylwia Szafraniec-Buryło, et al.
Archives of Medical Science : AMS|December 13, 2021
Overall survival of patients with <i>EGFR</i> mutation-positive non-small-cell lung cancer treated with erlotinib, gefitinib or afatinib under drug programmes in Poland - real-world dataMelania Brzozowska, Waldemar Wierzba, Sylwia Szafraniec-Buryło, et al.
Archives of Medical Science : AMS|June 14, 2023
Epidemiology of multiple myeloma in Poland in the years 2008-2017Anna Waszczuk-Gajda, Sylwia Szafraniec-Buryło, Leszek Kraj, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Przeglad Lekarski|November 3, 2004
[Anthrax as a bioweapon]Sylwia Szafraniec, Paweł Grzesiowski, Waleria Hryniewicz
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|May 6, 2003
[Modern possibilities of bioterrorism diagnosis]Paweł Grzesiowski, Sylwia Szafraniec, Beata Chmylak, et al.
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|December 17, 2021
Patient care efficiency in primary healthcare - pilot study in Medical and Diagnostical CentreArtur Prusaczyk, Magdalena Bogdan, Paweł Żuk, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|May 24, 2019
Real-World Evidence of Patient Outcome Following Treatment of Advanced Gastrointestinal Stromal Tumor (GIST) with Imatinib, Sunitinib, and Sorafenib in Publicly Funded Health Care in PolandMelania Brzozowska, Waldemar Wierzba, Sylwia Szafraniec-Buryło, et al.
Archives of Medical Science : AMS|December 13, 2021
Overall survival of patients with <i>EGFR</i> mutation-positive non-small-cell lung cancer treated with erlotinib, gefitinib or afatinib under drug programmes in Poland - real-world dataMelania Brzozowska, Waldemar Wierzba, Sylwia Szafraniec-Buryło, et al.
Archives of Medical Science : AMS|June 14, 2023
Epidemiology of multiple myeloma in Poland in the years 2008-2017Anna Waszczuk-Gajda, Sylwia Szafraniec-Buryło, Leszek Kraj, et al.
Pageof 1